Barclays analyst Maurice Patrick maintained a Buy rating on IHS Holding (IHS – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $3.76.
The Landesbank Hessen-Thüringen Girozentrale-Bond has a maturity date of 1/30/2031 and offers a coupon of 3.0000%. The payment of the coupon will take place 1.0 times per Year on the 30.01.. The ...
Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating ...
Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the ...
CHESTER, N.Y., Jan. 15, 2025 /PRNewswire/ -- Innovative Health Sciences (IHS) proudly announces a remarkable milestone in its journey to introduce the Insignis™ Infusion System into the global ...
Achieving MDR compliance at such an early stage highlights the dedication and expertise of the IHS team. This rigorous process required a meticulous adherence to MDR standards across all aspects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback